Black v. Wexford Health Source Inc.

CourtDistrict Court, S.D. Illinois
DecidedMarch 14, 2023
Docket3:20-cv-00678
StatusUnknown

This text of Black v. Wexford Health Source Inc. (Black v. Wexford Health Source Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Black v. Wexford Health Source Inc., (S.D. Ill. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

RODNEY EUGENE BLACK, #B86195,

Plaintiff, Case No. 20-cv-00678-SPM v.

WEXFORD HEALTH SOURCES, INC., DR. SIDDIQUI, and ANTHONY WILLS,

Defendants.

MEMORANDUM AND ORDER

MCGLYNN, District Judge: Plaintiff Rodney Black, an inmate in the Illinois Department of Corrections, filed this action pro se under 42 U.S.C. § 1983 for alleged deprivations of his constitutional rights. (Doc. 1). Plaintiff claims that he has been provided inadequate medical treatment for his back condition and associated pain. Pending before the Court is a Motion for Summary Judgment filed by Defendants Siddiqui and Wexford Health Sources, Inc. (“Wexford”) (Doc. 70), and a Motion for Summary Judgment filed by Defendant Wills (Doc. 73). Plaintiff has filed responses in opposition to the motions. (Doc. 77, 78). Defendants Siddiqui and Wexford have filed a reply brief. (Doc. 78). Now that this matter has been fully briefed, and for the reasons set forth below, the Court grants both motions for summary judgment. RELEVANT FACTS Following his conviction, Plaintiff was transferred to Menard Correctional Center in April 2019. (Doc. 71-3, p. 9-10). Dr. Siddiqui’s first appointment with Plaintiff was on July 3, 2019, for a recurrent lesion on the sole of his right foot. (Doc. 71-1, p. 2). At the appointment, Plaintiff did not complain of back pain. (Id.). From June through September of 2019, Plaintiff was seen six different times by other medical staff for complaints of back pain. (See Doc. 45-1).1 During this time, he was initially

treated with ibuprofen and acetaminophen and given low bunk and low gallery permits. On September 17, 2019, Plaintiff was scheduled to be seen by a doctor for his back pain, but he went to the commissary instead and missed his appointment. (Doc. 45-1, p. 17). Plaintiff was not seen for his back condition and pain by medical staff the remainder of the year, and he does not claim he submitted requests regarding back pain during this time. (See Doc. 76, p. 8). Dr. Siddiqui next saw Plaintiff on December 9 and December 24, 2019, for other unrelated medical conditions. (Doc. 71-1, p. 2; Doc. 71-2, p. 3-4). Plaintiff did not voice complaints of back pain at either appointment. (Id.). From January through April 2020, Plaintiff had six appointments with various medical staff for back pain.2 Plaintiff was prescribed Tylenol and Mobic/Meloxicam. He was evaluated and

approved for physical therapy, and x-rays were taken. Mobic/Meloxicam is a nonsteroidal anti- inflammatory drug (“NSAID”) used to treat arthritis. (Doc. 71-1, p. 2). In April, after further complaints of pain, the Mobic/Meloxicam prescription was increased, and Plaintiff was prescribed Robaxin. Plaintiff’s first appointment with Dr. Siddiqui regarding his back condition was on May 20, 2020. (Doc. 71-1, p. 8; Doc. 71-2, p. 8). Dr. Siddiqui recorded in the medical records that Plaintiff reported that he had a history of chronic back pain for fifteen years. Dr. Siddiqui noted

1 Plaintiff was seen by medical staff for complaints of back pain on the following dates: June 22, 2019, June 25, 2019, July 17, 2019, August 13, 2019, August 20, 2019, and September 13, 2019. (Doc. 45-1, p. 2, 3, 5, 9, 10-11, 14-16). 2 Plaintiff was seen on the following dates: January 17, 2020, January 22, 2020, February 12, 2020, February 20, 2020, March 24, 2020, and April 13, 2020. (Doc. 45-1, p. 22, 24, 26, 28, 31, 33). that the x-rays showed severe degenerative joint disease and that there were no spine deformities. Dr. Siddiqui’s analysis was that Plaintiff had severe osteoarthritis. At this appointment, Plaintiff requested the medicine Tramadol, a controlled substance that belongs to the group of medications called opioid analgesics. (Doc. 71-2, p. 8; Doc. 71-3, p. 17). Dr. Siddiqui ordered for Plaintiff to

continue taking Mobic/Meloxicam. (Doc. 71-2, p. 8). On June 18, 2020, Plaintiff had an appointment with a nurse practitioner, who noted he had a steady gait and no obvious signs of mobility deficits. (Doc. 45-1, p. 39). He was advised to continue with the Meloxicam and physical therapy. (Id.). On September 17, 2020, Plaintiff had another appointment with a nurse practitioner for his back pain. His low bunk and low gallery permit was renewed for one year, and the nurse practitioner noted to follow up with Plaintiff when he had completed physical therapy if he continued to have problems. (Doc. 45-1, p. 44, 49). On that same day Plaintiff had a physical therapy session. (Doc. 71-2, p. 13). According to the medical records, Plaintiff’s physical therapy appointments in 2020 were intermittent and not

twice a week as prescribed. During this time, it was noted more than once that Plaintiff had poor compliance or was not compliant at all in his exercises. (Doc. 45-1, p. 38, 40-42). On July 8, 2020, the recorder noted that “no exercises were completed.” (Id. at p. 41). At his finally session, Plaintiff reported having the “same symptoms.” (Doc. 71-2, p. 13). It was also noted that Plaintiff gives “minimal efforts during session, also does not do exercises at all.” (Id.). At this point, on September 17, his physical therapy sessions were discontinued. Plaintiff was advised to submit a request if the pain persists. On January 21, 2021, Plaintiff was seen by a nurse for back pain, who prescribed him ibuprofen and referred him for further evaluation by a doctor. (Doc. 45-2, p. 1). Plaintiff was seen by Dr. Siddiqui on February 1, 2021, who prescribed 600 mg tablets of ibuprofen and referred Plaintiff for another physical therapy evaluation. (Doc. 71-1, p. 3; Doc. 71-2, p. 28, 31). Plaintiff was seen by a nurse practitioner on March 17, 2021, who ordered updated x-rays and renewed the Robaxin prescription. (Doc. 45-2, p. 5). The x-rays were taken that same day. (Id.

at p. 6). Plaintiff was evaluated for physical therapy on March 24, 2021. (Id. at p. 10). At the appointment, the recorded noted that Plaintiff reported “muscle relaxers decrease his pain.” The recorded also wrote that Plaintiff would benefit from physical therapy with one of the goals being to “decrease pain 1-2 levels.” The recommended plan was for Plaintiff to have physical therapy two times a week for six weeks. (Id.). Plaintiff next saw Dr. Siddiqui on March 29, 2021, for complaints of pain in his dorsal spine. (Doc. 71-1, p. 3; Doc. 71-2, p. 17). Dr. Siddiqui noted that the x-rays showed degenerative changes, no deformities of the spine, and Plaintiff had a normal gate and ambulated normally. Dr. Siddiqui also recorded tenderness of the low dorsal spine on pressure. He submitted a request to collegial review for approval of an MRI of the thoracic spine based on “pain dorsal spine x-rays

degenerative disease.” (Doc. 71-1, p. 3; Doc. 71-2, p. 23). On April 5, 2021, a collegial was held regarding Dr. Siddiqui’s request for an MRI. (Doc. 71-2, p. 22). An alternative treatment plan was made to continue with physical therapy for 8-12 weeks, and a trial of “long acting NSAID DOT, Cymbalta, or nortriptyline.” (Id.).3 Dr. Siddiqui next met with Plaintiff on May 24, June 26, and July 21, 2021, for other medical issues. During these appointments, Plaintiff did not voice any complaints of back pain.

3 According to Defendants, “Cymbalta (Duloxetine) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) that can be used for pain caused by nerve damage associated with diabetes (diabetic peripheral neuropathy), fibromyalgia (muscle pain and stiffness), and chronic (long-lasting) pain that is related to muscles and bones,” and “Nortriptyline is a tricyclic antidepressant. Antidepressants are mainstays in the treatment of chronic pain conditions, including arthritis and low back pain.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
City of Oklahoma v. Tuttle
471 U.S. 808 (Supreme Court, 1985)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Berry v. Peterman
604 F.3d 435 (Seventh Circuit, 2010)
Delapaz v. Richardson
634 F.3d 895 (Seventh Circuit, 2011)
Arnett v. Webster
658 F.3d 742 (Seventh Circuit, 2011)
Forbes v. Edgar
112 F.3d 262 (Seventh Circuit, 1997)
Donald F. Greeno v. George Daley
414 F.3d 645 (Seventh Circuit, 2005)
John Anderson v. Patrick Donahoe
699 F.3d 989 (Seventh Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Rodriguez v. Plymouth Ambulance Service
577 F.3d 816 (Seventh Circuit, 2009)
Hayes v. Snyder
546 F.3d 516 (Seventh Circuit, 2008)
Gayton v. McCoy
593 F.3d 610 (Seventh Circuit, 2010)
Anne Spaine v. Community Contacts, Inc.
756 F.3d 542 (Seventh Circuit, 2014)
Joshua Bunn v. Khoury Enterprises, Inc.
753 F.3d 676 (Seventh Circuit, 2014)
Earnest D. Shields v. Illinois Department of Correct
746 F.3d 782 (Seventh Circuit, 2014)
John Doe v. Archdiocese of Milwaukee
743 F.3d 1101 (Seventh Circuit, 2014)
Christopher Pyles v. Magid Fahim
771 F.3d 403 (Seventh Circuit, 2014)
Tyrone Petties v. Imhotep Carter
836 F.3d 722 (Seventh Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Black v. Wexford Health Source Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/black-v-wexford-health-source-inc-ilsd-2023.